---
schema_version: "secwatch.filing_event.v1"
accession: "0001062993-23-013870"
form_type: "8-K"
ticker: null
cik: "0001617765"
company_name: "EVOME MEDICAL TECHNOLOGIES INC."
filed_at: "2023-06-20T23:59:59+00:00"
generated_at: "2026-06-13T21:20:30.243104+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Salona Global terminates CEO Luke Faulstick, appoints Michael Seckler as interim CEO

## Summary
- Luke Faulstick terminated as President and CEO effective June 13, 2023; remains on the board.
- Michael Seckler appointed Interim CEO; previously senior executive at Ferring/FerGene.
- Joseph Martinez terminated as SVP Legal, General Counsel, Secretary; available as hourly consultant.
- Company prioritizing cash flow from operations and debt restructuring per chairman.
- Seckler receives $100k salary, up to $200k variable comp, and 250,000 options at CAD$0.25.

## SEC filing metadata
- accession: 0001062993-23-013870
- form_type: 8-K
- cik: 0001617765
- company_name: EVOME MEDICAL TECHNOLOGIES INC.
- filed_at: 2023-06-20T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1617765/000106299323013870/0001062993-23-013870-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1617765/000106299323013870/form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001062993-23-013870
- JSON: https://secwatch.observer/filing/0001062993-23-013870.json
- Plain text: https://secwatch.observer/filing/0001062993-23-013870.txt

## Key facts
- Executive change
  Luke Faulstick was terminated as President and Chief Executive Officer at EVOME MEDICAL TECHNOLOGIES INC..
  - Action: terminated
  - Role: President and Chief Executive Officer
  source text: On June 13, 2023, Salona Global Medical Device Corporation (the "Company") exercised its right to terminate the employment of Luke Faulstick as the Company's President and Chief Executive Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1617765/000106299323013870/0001062993-23-013870-index.htm
- Executive change
  Joseph Martinez was terminated as Senior Vice President, Legal & Compliance, General Counsel and Secretary at EVOME MEDICAL TECHNOLOGIES INC..
  - Action: terminated
  - Role: Senior Vice President, Legal & Compliance, General Counsel and Secretary
  source text: on June 13, 2023 he ceased to hold the titles of Senior Vice President, Legal & Compliance, General Counsel and Secretary of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1617765/000106299323013870/0001062993-23-013870-index.htm
- Executive change
  Michael Seckler was appointed as Interim Chief Executive Officer at EVOME MEDICAL TECHNOLOGIES INC..
  - Action: appointed
  - Role: Interim Chief Executive Officer
  source text: On June 13, 2023, upon terminating Mr. Faulstick, the Company appointed Michael Seckler, 58, to the position of Interim Chief Executive Officer, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1617765/000106299323013870/0001062993-23-013870-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.